Immunologists have known for decades that immunity is the result of the various contributions of cell-mediated and antibody-mediated responses. Within recent years the dichotomy of possible immune responses has been further defined by the knowledge that T helper cells can adopt one of two polar types of reactivity: T helper 1 (Th1) and T helper 2 (Th2). These counter responses can be differentiated by differences in the phenotype of cytokines (Th1, IFNgamma; Th2, IL4, IL10) and isotypes of antibodies (Th1: IgG2a; Th2: IgG1, IgE) they make. Th1 responses are associated with inflammation, while Th2 responses are associated with inflammation, while Th2 responses associated with hypersensitivity and protection against parasitic invasion. Because these two polar responses cross regulate each other it is possible that Th2 responses might be important in the prevention of inflammation in various organs including the eye. Apparently, in the health eye, it is very difficult to induce a Th1 response because of an unusual local regulatory mechanism in the anterior chamber. This research proposal will study the ocular regulatory mechanism known as Anterior Chamber Associated Immune Deviation (ACAID). ACAID is relevant to the up-regulation of Th2 responses and the down regulation of Th1 responses, i.e. inflammation, thereby preserving sight. In an animal model antigenic materials that are placed in the anterior chamber (a.c.) Of the eye evoke a systemic immune response that is distinctly unusual in there is a selective deficiency of delayed-type hypersensitivity (DTH, an indicator of a Th1, response). While this model is well studied, no one has looked at early mechanisms that might be invoked to produce and maintain an ocular Th2 response. We propose that two distinct subpopulations of lymphocytes expressing natural killer (NK) antigens may participate in the early regulation of the polar responses to antigens inoculated into the anterior chamber. Recent data from our laboratory show that ACID does not develop in CD1 deficient mice. This application will exploit this observation by studying the mechanisms and interaction of NKT cells and CD1. We will use a variety of methods to test the hypotheses including flow cytometry with simultaneous labeling of intracellular cytokines and surface markers, morphological analysis of cells in tissues and suspension, molecular biology techniques, including Rnase protection assay. In addition we will evaluate the role of NK antigen positive lymphocytes in whole animal models that are manipulated to prevent ACID and compare ACAID in naive and primed mice. Resents of the studies will generate new information toward understanding the cellular mechanisms of immune deviation in the eye and new insights into the interactions of NKT (innate immunity) and the adaptive immune response.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY011983-03
Application #
6384714
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Liberman, Ellen S
Project Start
1999-04-01
Project End
2002-12-31
Budget Start
2001-04-01
Budget End
2002-12-31
Support Year
3
Fiscal Year
2001
Total Cost
$358,783
Indirect Cost
Name
Schepens Eye Research Institute
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Hsu, S-M; Mathew, R; Taylor, A W et al. (2014) Ex-vivo tolerogenic F4/80? antigen-presenting cells (APC) induce efferent CD8? regulatory T cell-dependent suppression of experimental autoimmune uveitis. Clin Exp Immunol 176:37-48
Lucas, Kenyatta; Karamichos, Dimitris; Mathew, Rose et al. (2012) Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege. J Immunol 189:1237-42
Qiao, Hong; Lucas, Kenyatta; Stein-Streilein, Joan (2009) Retinal laser burn disrupts immune privilege in the eye. Am J Pathol 174:414-22
Watte, C M; Nakamura, T; Lau, C H et al. (2008) Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance. J Leukoc Biol 83:928-35
Sonoda, Koh-Hei; Nakamura, Takahiko; Young, Howard A et al. (2007) NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J Immunol 179:2215-22
Nowak, Michael; Stein-Streilein, Joan (2007) Invariant NKT cells and tolerance. Int Rev Immunol 26:95-119
Sugita, Sunao; Keino, Hiroshi; Futagami, Yuri et al. (2006) B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest Ophthalmol Vis Sci 47:5376-84
Keino, Hiroshi; Takeuchi, Masaru; Kezuka, Takeshi et al. (2006) Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest Ophthalmol Vis Sci 47:1047-55
Keino, Hiroshi; Masli, Sharmila; Sasaki, Shuji et al. (2006) CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance. Invest Ophthalmol Vis Sci 47:1533-42
Zhang-Hoover, Jie; Finn, Patricia; Stein-Streilein, Joan (2005) Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC. J Immunol 175:7117-24

Showing the most recent 10 out of 20 publications